Anticipated $-0.14 EPS for OPKO Health, Inc. (OPK) on May, 8

April 16, 2018 - By Georgina Andrews

During 2017 Q4 the big money sentiment decreased to 0.84. That’s change of 0.30, from 2017Q3’s 1.14. 32 investors sold all, 60 reduced holdings as OPKO Health, Inc. ratio dived. 53 increased stakes while 24 funds bought stakes. Funds hold 119.15 million shares thus 0.51% less from 2017Q3’s 119.76 million shares.
State Of Alaska Department Of Revenue owns 29,600 shs for 0% of their capital. Hyman Charles D has 18,119 shs for 0.01% of their capital. North Star Investment Management invested 0.02% of its capital in OPKO Health, Inc. (NASDAQ:OPK). Stone Ridge Asset Mngmt Limited reported 45,100 shs or 0.01% of all its holdings. Hollencrest Management reported 45,000 shs. 228,780 are owned by Boulegeris Investments Inc. 278,680 are owned by Virtu Finance Limited Liability. 61,500 are owned by Utah Retirement Systems. Empirical Service reported 0.02% of its capital in OPKO Health, Inc. (NASDAQ:OPK). First Trust Ltd Partnership, a Illinois-based fund reported 31,328 shs. Horrell Capital Mngmt holds 0% or 300 shs in its capital. Moreover, State Board Of Administration Of Florida Retirement Sys has 0.01% invested in OPKO Health, Inc. (NASDAQ:OPK). Moreover, Employees Retirement Association Of Colorado has 0% invested in OPKO Health, Inc. (NASDAQ:OPK). Jaffetilchin Investment Prtnrs Limited Com reported 943,039 shs or 1.54% of all its holdings. 165,203 are held by Barclays Pcl.

OPKO Health, Inc. registered $9.09 million net activity with 35 buys and 0 sales since January 22, 2018. Fishel Robert Scott bought $31,600 worth of stock. On Tuesday, March 13 a trade for 2,065 shs valued at $7,011 was made by Logal Adam. $19,500 worth of OPKO Health, Inc. (NASDAQ:OPK) was bought by Rubin Steven D on Wednesday, March 7.

On May, 8 OPKO Health, Inc. (NASDAQ:OPK)’s earnings report is expected by WallStreet, RTT reports. Analysts predict 133.33 % diference or $-0.14 from the $-0.06 EPS from 2017. Last quarter $-0.12 EPS was reported. Analysts forecasts 16.67 % negative EPS growth this quarter. OPK reached $3.02 on during the last trading session after $0.03 change.Currently OPKO Health, Inc. is downtrending after 60.81% change in last April 17, 2017. OPK has 2.61 million shares volume. OPK underperformed the S&P500 by 72.36%.

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, and Mexico.The company has $1.69 billion market cap. The company's Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases.Currently it has negative earnings. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform.

OPKO Health, Inc. (NASDAQ:OPK) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.